From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

Objectives

  • Describe the financial impact of HCV treatment
  • Identify current restrictions to HCV treatment common among third party payers
  • Illustrate successful navigation through the prior authorization and appeal process
  • Review criteria and options for patient assistance programs (PAP)

Speaker

Autumn Bagwell PharmD BCPS

Check all that apply
Check all that apply
By submitting this form, you accept the Mollom privacy policy.

Add comment

Log in to post comments